ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 9 filers reported holding ESSA PHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,310,000 | -49.0% | 2,003,103 | 0.0% | 0.02% | -32.3% |
Q1 2022 | $12,379,000 | -73.6% | 2,003,103 | -39.4% | 0.03% | -73.5% |
Q4 2021 | $46,904,000 | +77.5% | 3,303,103 | 0.0% | 0.12% | +98.3% |
Q3 2021 | $26,425,000 | -72.0% | 3,303,103 | 0.0% | 0.06% | -72.3% |
Q2 2021 | $94,370,000 | -9.1% | 3,303,103 | -7.6% | 0.21% | +2.9% |
Q1 2021 | $103,797,000 | +143.5% | 3,573,053 | 0.0% | 0.21% | +38.0% |
Q4 2020 | $42,627,000 | +72.9% | 3,573,053 | 0.0% | 0.15% | +56.2% |
Q3 2020 | $24,654,000 | +17.9% | 3,573,053 | +5.9% | 0.10% | +9.1% |
Q2 2020 | $20,913,000 | +55.0% | 3,373,053 | 0.0% | 0.09% | -10.2% |
Q1 2020 | $13,492,000 | -27.3% | 3,373,053 | 0.0% | 0.10% | -19.0% |
Q4 2019 | $18,552,000 | +63.2% | 3,373,053 | 0.0% | 0.12% | +86.2% |
Q3 2019 | $11,367,000 | +178.1% | 3,373,053 | +102.2% | 0.06% | +209.5% |
Q2 2019 | $4,088,000 | -27.9% | 1,668,560 | 0.0% | 0.02% | -25.0% |
Q1 2019 | $5,673,000 | +61.9% | 1,668,560 | 0.0% | 0.03% | +40.0% |
Q4 2018 | $3,504,000 | – | 1,668,560 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |